Literature DB >> 30199313

Effect of Nebulizer Location and Spontaneous Breathing on Aerosol Delivery During Airway Pressure Release Ventilation in Bench Testing.

Hui-Qing Ge1, Ji-Mei Wang1, Hui-Ling Lin2, James B Fink3, Ronghua Luo4, Peifeng Xu1, Kejing Ying5.   

Abstract

BACKGROUND: Airway pressure release ventilation (APRV) maintains a sustained airway pressure over a large proportion of the respiratory cycle, and has a long inspiratory time at high pressure. The purpose of this study was to determine the influence of the APRV with and without spontaneous breathing on albuterol aerosol delivery with a continuous vibrating-mesh nebulizer (VMN) placed at different positions on an adult lung model of invasive mechanical ventilation.
METHODS: An adult lung model was assembled by connecting a ventilator with a dual-limb circuit to an 8-mm inner diameter endotracheal tube (ETT) and collecting filter attached to a test lung with set compliance of 0.1 L/cmH2O and resistance of 0.5 cmH2O/(L·s). Four ventilator modes were compared: pressure control ventilation (PCV) with no bias flow, PCV with bias flow of 6 L/min (PCVBF6), APRV with no spontaneous breaths (APRV), and APRV with spontaneous breath trigger (APRVs). Peak inspiratory pressure, peak end-expiratory pressure, aerosol dose, and nebulization time were similar for all modes. The VMN was placed (1) between Y-piece and inspiratory limb, (2) at the gas outlet of a heated humidifier, and (3) at the gas inlet of a heated humidifier. Albuterol sulfate (5 mg/2.5 mL) was administered with each run and collected on a filter distal to the ETT. Deposited drug was eluted from each filter (purified water) and analyzed by UV spectrophotometry at 276 nm. Analysis of variance [general linear model (GLM) multivariate] was performed using the linear model of multiple variables, significance at p < 0.05.
RESULTS: Albuterol (in micrograms, mean ± standard deviation) delivered was higher with VMN placed at the gas inlet of the humidifier with each mode of ventilation (p < 0.01). APRVs has the highest albuterol delivery followed by PCV, PCVBF6, and APRV (1706.2 ± 60.9 μg vs. 1490.6 ± 61.1 μg vs. 1182.3 ± 61.4 μg vs. 1153.1 ± 99.7 μg, respectively, p < 0.001). The minute volume was positively correlated with the inhaled albuterol dose.
CONCLUSIONS: Spontaneous breathing increased the albuterol delivery during APRV, compared with APRV alone and PCV modes. Placing the nebulizer proximal to the ventilator was more efficient for all modes tested.

Entities:  

Keywords:  aerosol delivery; airway pressure release ventilation; bench testing; spontaneous breath; ventilation mode; vibrating-mesh nebulizer

Mesh:

Substances:

Year:  2018        PMID: 30199313     DOI: 10.1089/jamp.2018.1457

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  4 in total

Review 1.  Aerosol delivery via invasive ventilation: a narrative review.

Authors:  Hui-Ling Lin; James B Fink; Huiqing Ge
Journal:  Ann Transl Med       Date:  2021-04

2.  Practice pattern of aerosol therapy among patients undergoing mechanical ventilation in mainland China: A web-based survey involving 447 hospitals.

Authors:  Zhongheng Zhang; Peifeng Xu; Qiang Fang; Penglin Ma; Huiling Lin; Jim B Fink; Zongan Liang; Rongchang Chen; Huiqing Ge
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

3.  Size Distribution of Colistin Delivery by Different Type Nebulizers and Concentrations During Mechanical Ventilation.

Authors:  Ching-Yi Liu; Hsin-Kuo Ko; James B Fink; Gwo-Hwa Wan; Chung-Chi Huang; Yu-Chun Chen; Hui-Ling Lin
Journal:  Pharmaceutics       Date:  2019-09-05       Impact factor: 6.321

4.  Effect of Perineum Block Anesthesia Combined with Unprotected Perineal Delivery on the Perineal Integrity Rate and Maternal-Infant Outcomes in Primiparas Taking Health Products Containing Traditional Chinese Medicine.

Authors:  Xu Liu; Jianyun Ge; Jiejie Zhang; Boxiang Du
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-01       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.